Submissions

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

I registered in Congress before submitting the article.
The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
Where available, URLs for the references have been provided.
The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Overview

Date ^a	Notification

Dec 20, 2022	Abstract Submission Deadline
Jan 05, 2023	Abstract Modification and Withdrawal Deadline
Jan 20, 2023	Final Abstract Status Notification
Jan 25, 2023	ePoster Upload Deadline
Feb 2-4, 2023	ISRO 2023

^a All deadlines are 11:59 PM Tehran time (UTC + 3:30)

Submission Regulations

Abstract submission deadline for ISRO 2023 is on December 20, 2022.
Abstracts must be submitted online via the iscocongress@gmail.com.
In case of abstract withdrawal, please submit your requests in writing via email to iscocongress@gmail.com by January 25, 2022, with your submission ID number(s).
For any questions regarding the online submission process, please email iscocongress@gmail.com.

Aim and Scope

3.1. Clinical abstracts:

Breast cancer
CNS tumors
Cancer management in COVID-19 era
Cancer screening
Endocrine and neuroendocrine tumors
Gastrointestinal cancers
Genitourinary cancers
Gynecology cancers
Head and neck cancers
Hematological malignancies
Lung cancers
Palliative care
Psyco-oncology
Pediatric tumors
Sarcoma
Skin cancers

3.2. Physics abstracts:

3.3. Radiobiology abstracts:

Normal tissue radiobiology
Tumor radiobiology
Immuno-radiobiology
Microenvironment

3.4. RTT abstracts:

Criteria for acceptance

4.1. Originality: By submitting an abstract intended for presentation at ISRO 2023, the first author (= presenter) warrants that the materials have not been previously published in any publication (in peer review setting) before February 15, 2023.

4.2. Accepted manuscript formats

Original research
Systematic review
Meta-analysis
We will not consider:
- Reviews
- Case reports/case series
- Hypothesis or proposal papers
- Letters, commentaries, or essays
- Opinion pieces
- Policy papers
- Clinical practice guidelines
- Any other type of secondary literature
- Monographs

4.3. Abstract structure

Author names and affiliations should not be present in the abstract title and abstract content as the abstract must be blinded for review.
The title of the abstract should include significant keywords that reflect the content of the abstract
Abstracts must not exceed 350 words. Deduct 50 words for each table, graphs or figures included. For example, with two figures, the maximum word count is 250.
Images are not permitted as they do not reproduce well. Brief and clear tables, graphs, and figures are accepted (maximum of 1 page on US Letter, 8.5 x 11-inch paper).
The abstract is presented in an intelligible fashion and is written in standard English
The abstract must include the main headings of Background and Objectives, Methods, Results, and Conclusions
Methods cover the main experiments and analysis (if any)
Results cover the findings on primary (and secondary, if any) objective
Conclusions are presented in an appropriate fashion and are supported by the data
Use generic terms for drug names
Standard abbreviations may be used without definition. Nonstandard abbreviations should be kept to a minimum and placed in parentheses after the first use of the word or phrase
Use International System (SI) for units

Review Process

Each abstract will be blinded and scored by up to two reviewers.
The reviewers are selected based on the abstract category (clinical, physics, radiobiology, RTT)
Abstracts will be accepted on the basis of scientific merit and originality.
Overall, bear in mind that your abstract will be rated according to the following criteria:
- is the design of the study valid?
- are the methods appropriate?
- what is the significance of the results?

Articles

Section default policy

Copyright Notice

Require authors to agree to the following copyright notice as part of the submission process.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.